Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Combination Of The Parp Inhibitor Veliparib (Abt888) With Irinotecan In Patients With Triple Negative Breast Cancer: Preliminary Activity And Signature Of Response

Patricia LoRusso,Sara M. Tolaney,Shukmei Wong,Ralph E. Parchment,Robert J. Kinders,Lihua Wang,Jessica Aldrich,Alice Chen,Diane Durecki,Scott Boerner,Tina Guthrie,Adam Bowditch,Lance K. Heilbrun,Mary Jo Pilat,David Craig,Dongpo Cai,Tracy Bell,John D. Carpten,Geoffrey I. Shapiro

CANCER RESEARCH（2015）

Cited 5|Views44
No score
Key words
parp inhibitor veliparib,triple negative breast cancer,negative breast cancer,irinotecan,breast cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined